PAM
PFE icon

Pegasus Asset Management’s Pfizer PFE Stock Holding History

Pegasus Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Buy
+7,235
New +$193K 0.07% 67
2025
Q2 		– Sell
-9,112
Closed -$231K – 74
2025
Q1 		$231K Sell
9,112
-1,732
-16% -$45.3K 0.09% 61
2024
Q4 		$288K Sell
10,844
-2,768
-20% -$75.1K 0.11% 57
2024
Q3 		$394K Hold
13,612
– – 0.15% 55
2024
Q2 		$381K Hold
13,612
– – 0.15% 59
2024
Q1 		$378K Sell
13,612
-235
-2% -$6.52K 0.15% 60
2023
Q4 		$399K Sell
13,847
-348
-2% -$10.5K 0.17% 60
2023
Q3 		$471K Sell
14,195
-1,313
-8% -$46.4K 0.22% 58
2023
Q2 		$569K Sell
15,508
-75
-0.5% -$2.92K 0.25% 57
2023
Q1 		$636K Sell
15,583
-20
-0.1% -$864 0.32% 51
2022
Q4 		$799K Sell
15,603
-340
-2% -$16.3K 0.43% 48
2022
Q3 		$698K Hold
15,943
– – 0.39% 53
2022
Q2 		$836K Hold
15,943
– – 0.45% 49
2022
Q1 		$825K Sell
15,943
-12
-0.1% -$623 0.36% 57
2021
Q4 		$942K Buy
15,955
+12
+0.1% +$595 0.39% 55
2021
Q3 		$686K Hold
15,943
– – 0.31% 62
2021
Q2 		$624K Hold
15,943
– – 0.29% 62
2021
Q1 		$578K Buy
15,943
+1,190
+8% +$42.3K 0.29% 62
2020
Q4 		$543K Sell
14,753
-711
-5% -$26.1K 0.3% 60
2020
Q3 		$538K Hold
15,464
– – 0.34% 59
2020
Q2 		$480K Sell
15,464
-422
-3% -$14.3K 0.33% 57
2020
Q1 		$491K Sell
15,886
-831
-5% -$28.3K 0.41% 52
2019
Q4 		$621K Buy
16,717
+199
+1% +$7.09K 0.41% 54
2019
Q3 		$563K Sell
16,518
-3,057
-16% -$111K 0.41% 55
2019
Q2 		$805K Sell
19,575
-1,452
-7% -$57.7K 0.62% 49
2019
Q1 		$847K Sell
21,027
-527
-2% -$21.1K 0.7% 46
2018
Q4 		$893K Hold
21,554
– – 0.84% 42
2018
Q3 		$901K Sell
21,554
-896
-4% -$34.5K 0.75% 45
2018
Q2 		$773K Sell
22,450
-1,054
-4% -$36K 0.72% 48
2018
Q1 		$791K Sell
23,504
-766
-3% -$26.3K 0.75% 49
2017
Q4 		$834K Buy
+24,270
New +$828K 0.83% 47

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Pegasus Asset Management's PFE Position: Q1 2026 in Review

Pegasus Asset Management opened a new position in Pfizer (PFE) in Q1 2026: 7,235 shares worth $203K. The stake represents 0.07% of the portfolio and ranks #67 among its holdings. This is a return to the name: Pegasus Asset Management previously reported a position in PFE as recently as Q1 2025.

Pegasus Asset Management first reported a position in PFE in Q4 2017 and has held it in 31 quarters since. The position peaked at $942K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Pegasus Asset Management held 7,235 shares of Pfizer worth $203K as of Q1 2026.
  • Pfizer was a new Pegasus Asset Management position in Q1 2026.
  • Pfizer made up 0.07% of Pegasus Asset Management's portfolio in Q1 2026, its #67 holding.
  • Pegasus Asset Management first reported a position in Pfizer in Q4 2017 and has held it in 31 quarters since.
  • Pegasus Asset Management's Pfizer position peaked at $942K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Pegasus Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.